NLA to unveil new scientific statements, focus on ‘lower is better’ for LDL management
Click Here to Manage Email Alerts
The National Lipid Association Scientific Sessions, a hybrid meeting held Sept. 24-26, 2021, will include four featured sessions, updates on NLA scientific statements and numerous abstract presentations.
This year, the meeting will be delivered through a virtual education program as well as in-person sessions in Orlando, Florida. Subsequently, all streamed sessions will be made available on demand from approximately 1 week after the live sessions through Dec. 31, 2021.
Meeting highlights
“There is a prevailing trend in the field of lipidology ... that lower is better and lower for longer is better, and these are themes that are going to be carried forward in our field,” Daniel Soffer, MD, FNLA, clinical associate professor of medicine in the division of general internal medicine and translational medicine at the Perelman School of Medicine of the University of Pennsylvania, and former president of the Northeast chapter of the NLA. “Mary McGowan, MD, FNLA, is opening Session I with an LDL lowering update, talking about some of the new research, together with Christie Ballantyne, MD, FNLA, and Kevin Maki, PhD, CLS, FNLA, and that is going to set the tone for the ‘lower is better’ trend.”
The “Update on the Dyslipidemia Research Pipeline” session will take place Friday, Sept. 24, at 9:10 a.m. EDT, and will include McGowan’s “LDL Lowering Therapies — One Size Doesn't Fit All,” Ballantyne’s “Triglyceride and Lp(a) Lowering Medications” and Maki’s “CV Outcome Trials.”
“The thing I look forward to more than anything else with the upcoming conference is being in the same room with my colleagues rather than virtual,” Soffer told Healio. “The upcoming conferences focusing on novel therapeutics and the two NLA Scientific Statements are real highlights.”
The NLA scientific statements presented on Friday include “Lipid Measurements in the Management of Cardiovascular Diseases,” presented by Lynne Braun, PhD, CLS, FNLA, professor emerita in the department of adult health and gerontological nursing at Rush University College of Nursing, and “Genetic Testing in Dyslipidemia,” presented by Peter W. F. Wilson, MD, professor of medicine in the division of cardiology at Emory University School of Medicine.
In addition, Kausik Ray, MBChB, MD, MPhil, professor of public health, director of the Imperial Centre for CVD Prevention, deputy director of Imperial Clinical Trials Unit, head of commercial trials and consultant cardiologist at Imperial College London will host a virtual lecture on data from the ORION trials of inclisiran (The Medicines Company) for LDL lowering.
Diversity and inclusion
“In addition, the attention to implementation issues and inclusion/diversity remain challenges for clinicians that will be a focus of one of the sessions,” Soffer told Healio.
On Saturday, Sep. 25, Cardiology Today Editorial Board Member Keith C. Ferdinand, MD, professor of medicine, John W. Deming department of medicine, Tulane University School of Medicine, Angela Brown, MD, professor of medicine in the division of cardiology and vice chair for health equity for the department of medicine at Washington University School of Medicine, and Anekwe Onwuanyi, MD, chief of cardiology at Morehouse School of Medicine, will discuss health inequities in the U.S. This session will provide an overview of inequities as well as address specific disparities as they relate to Black and Hispanic residents.
NLA Scientific Session attendees can also view the “Late Breakers and Partner Abstracts” on Sunday at 11:00 a.m. Presentations include “Prevalence of Nonalcoholic Fatty Liver Disease in Subjects with Severe Hypertriglyceridemia — Initial Baseline Data from an Ongoing Phase 2 Study,” and “Ordering Trends and Report Outcomes for Lipid Genes on a Comprehensive Cardiovascular Genetics Menu.”
Healio will be providing the latest news from the NLA Scientific Session, with physician perspective, researcher interviews and clinician insight that can be read here.
Collapse
Healio Interviews
Click Here to Manage Email Alerts